Read + Share
Stoddart A, Fernald AA, Davis EM, McNerney ME, et al. EGR1 haploinsufficiency confers a fitness advantage to hematopoietic stem cells
following chemotherapy. Exp Hematol 2022 Aug 19. pii: S0301-472X(22)00679.
PMID: 35995095
|
 |
|
Stoddart A, Fernald AA, Davis EM, McNerney ME, et al. EGR1 haploinsufficiency confers a fitness advantage to hematopoietic stem cells
following chemotherapy. Exp Hematol 2022 Aug 19. pii: S0301-472X(22)00679.
PMID: 35995095
|
|
|
|